Congress Passes Zika Funding Bill

Congress passed and President Obama signed a 10-week continuing resolution, which includes $1.1 billion for Zika virus research.

ASM Acts to Counter Zika Virus Outbreak

The emerging threat of Zika virus infection.

ASM Urges Action to Combat Zika Emergency

Current events linked to the Zika virus make aggressive public health actions and funding to combat this emerging infectious disease more crucial than ever.
Become a member today!
Submit Abstracts for Biothreats 2017
Antibacterial Development Conference

RileyProfessor of Epidemiology and Infectious Diseases, Chair, Division of Infectious Diseases & Vaccinology, School of Public Health, University of California, Berkeley
Dr. Riley obtained his M.D. from the University of California, San Francisco, after which he completed his residency in internal medicine at Columbia Presbyterian Hospital in New York City. Soon after, Riley began working in the field of infectious diseases. His distinguished career has seen him work for both the Centers for Disease Control and the World Health Organization. He has also worked on international projects in many diverse countries such as Mexico, India, Bangladesh, the Philippines and Brazil and has published extensively (a textbook on Molecular Epidemiology, book chapters and research articles) on Mycobacterium tuberculosis, Escherichia coli, and other infectious agents. Riley is currently the Director of the Fogarty International Center Global Infectious Disease Program and the Chair of the Division of Infections Disease and Vaccinology at the University of California, Berkeley. He is a member of ASM and of the American Academy of Microbiology. He also holds an Adjunct Professor of Medicine position at Weill Medical College of Cornell University and serves as a national judge for the Young Epidemiology Scholars (YES) competition and as a member of the Clinical Research/Field Studies Infectious Diseases Study Section at the National Institutes of Health.